Zhou, Yukun http://orcid.org/0000-0002-0840-6422
Chia, Mark A.
Wagner, Siegfried K.
Ayhan, Murat S. http://orcid.org/0000-0002-3184-2353
Williamson, Dominic J. http://orcid.org/0000-0001-5219-9312
Struyven, Robbert R. http://orcid.org/0000-0002-2201-859X
Liu, Timing http://orcid.org/0000-0003-2834-3040
Xu, Moucheng
Lozano, Mateo G. http://orcid.org/0000-0003-1686-7189
Woodward-Court, Peter http://orcid.org/0000-0002-7913-1403
Kihara, Yuka
Allen, Naomi
Gallacher, John E. J.
Littlejohns, Thomas
Aslam, Tariq
Bishop, Paul
Black, Graeme
Sergouniotis, Panagiotis
Atan, Denize
Dick, Andrew D.
Williams, Cathy
Barman, Sarah
Barrett, Jenny H.
Mackie, Sarah
Braithwaite, Tasanee
Carare, Roxana O.
Ennis, Sarah
Gibson, Jane
Lotery, Andrew J.
Self, Jay
Chakravarthy, Usha
Hogg, Ruth E.
Paterson, Euan
Woodside, Jayne
Peto, Tunde
Mckay, Gareth
Mcguinness, Bernadette
Foster, Paul J.
Balaskas, Konstantinos
Khawaja, Anthony P.
Pontikos, Nikolas
Rahi, Jugnoo S.
Lascaratos, Gerassimos
Patel, Praveen J.
Chan, Michelle
Chua, Sharon Y. L.
Day, Alexander
Desai, Parul
Egan, Cathy
Fruttiger, Marcus
Garway-Heath, David F.
Hardcastle, Alison
Khaw, Sir Peng T.
Moore, Tony
Sivaprasad, Sobha
Strouthidis, Nicholas
Thomas, Dhanes
Tufail, Adnan
Viswanathan, Ananth C.
Dhillon, Bal
Macgillivray, Tom
Sudlow, Cathie
Vitart, Veronique
Doney, Alexander
Trucco, Emanuele
Guggeinheim, Jeremy A.
Morgan, James E.
Hammond, Chris J.
Williams, Katie
Hysi, Pirro
Harding, Simon P.
Zheng, Yalin
Luben, Robert
Luthert, Phil
Sun, Zihan
McKibbin, Martin
O’Sullivan, Eoin
Oram, Richard
Weedon, Mike
Owen, Chris G.
Rudnicka, Alicja R.
Sattar, Naveed
Steel, David
Stratton, Irene
Tapp, Robyn
Yates, Max M.
Petzold, Axel
Madhusudhan, Savita
Altmann, Andre http://orcid.org/0000-0002-9265-2393
Lee, Aaron Y.
Topol, Eric J. http://orcid.org/0000-0002-1478-4729
Denniston, Alastair K. http://orcid.org/0000-0001-7849-0087
Alexander, Daniel C. http://orcid.org/0000-0003-2439-350X
Keane, Pearse A.
,
Article History
Received: 5 December 2022
Accepted: 18 August 2023
First Online: 13 September 2023
Competing interests
: P.A.K. has acted as a consultant for DeepMind, Roche, Novartis, Apellis and BitFount, and is an equity owner in Big Picture Medical. He has received speaker fees from Heidelberg Engineering, Topcon, Allergan and Bayer.